Your SlideShare is downloading. ×
Grupo 4 ppt
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Grupo 4 ppt

833
views

Published on

Published in: Technology, Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
833
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • l
  • Here is the top lead compund obtained in the secondary screening with a binding energy of -10.6.That drug was preveiously known. (comercially available)
  • Here are the different amino acids that are interacting with the drug.
  • Model of the drug with the chemical featuresThis was other drug, it wasn’t that different.
  • Usellos
  • both
  • Transcript

    • 1. Secondary Screening: Vina Docking and Ranking by Binding Energy Juan C. Torres Carolina Montanez Gretel Montanez Luzmarie Reyes
    • 2. ObjectiveTo perform a secondary screening to identify theusing AutoDock Vina.
    • 3. Drug Discovery Strategy Biological Problem (Biomedically Relevant Condition or Process) Primary Sequence Optimal target (s) Analysis; degree for drug development conservationTherapeutically (NCBI/Swiss-Prot) FTmap Target Analysis Chemical probes Number, qualityrelevant protein cluster and distance of targets number & quality “hot spots’ Pharmacophore . 3D Structure identification and www.pdb.org PyMol Pharmacophore Model Generation (LigandScout) Primary Screening: Pharmacophore Drug-like Databases Model (≈ 9.5 million drugs) (Ligand Scout) Lead-like Database Further refinement (≈ 1.3 million drugs) of Pharmacophore Model Identification of Top Hits Secondary Screening (AutoDock) Identification of High Affinity Lead Compounds. BioAssay Lead (Ranking of binding Compounds energies)
    • 4. Part 1: Run the Docking Screening (AutoDock Vina)
    • 5. Part 2: Obtain the Results/ Ranking of Top Hits
    • 6. Part 3: Analyze Interactions using Auto Dock tools
    • 7. Pharmacophore Generation
    • 8. Part 4: Possible Model Refinement
    • 9. Conclusion• Our drug model did not have the same chemical features as the one generated and used in the primary screening.• The initial model can be refined.